History of drug or alcohol dependency within six months prior to signing the informed consent form

Concomitant administration of any medications known to affect blood pressure, except medications allowed by the protocol

Any investigational drug therapy within one month of signing the informed consent

Known hypersensitivity to any component of the study drugs (telmisartan, amlodipine, or placebo)

History of non-compliance or inability to comply with prescribed medications or protocol procedures

Any other clinical condition which, in the opinion of the investigator, would not allow safe completion of the protocol and safe administration of telmisartan and amlodipine

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00877929